| 1660 |
Root cause analysis for low performance in in Percentage of People Living with HIV (PLHIV) given Isoniazid (INH) Preventive Treatment (IPT) Against Total Eligible PLHIV |
17/05/2023 |
|
| 3193 |
Senior DR-TB/TB-HIV Supervisor and their role |
13/06/2023 |
|
| 3194 |
Interaction of Senior DR-TB/TB-HIV Supervisor with the TB Patient Care Ecosystem |
13/06/2023 |
|
| 3205 |
Overview of TB-HIV Collaborative Activities under NTEP |
13/06/2023 |
|
| 3254 |
Role of the Senior DR-TB/TB-HIV Supervisor in diagnostic centres |
13/06/2023 |
|
| 1847 |
Nodal DR-TB Centre |
13/06/2023 |
|
| 3252 |
Role of the Senior DR-TB/TB-HIV Supervisor at the ART/ICTC centres |
13/06/2023 |
|
| 3256 |
Supervisory activities by the Senior DR-TB/TB-HIV Supervisor |
13/06/2023 |
|
| 3255 |
Supervisory role of the Senior DR-TB/TB-HIV Supervisor for DR-TB patients |
13/06/2023 |
|
| 2394 |
Recording reconstitution in Ni-kshay Aushadhi |
13/06/2023 |
|
| 2389 |
Recording box preparation in Ni-kshay Aushadhi |
13/06/2023 |
|
| 268 |
Recording manual doses in Ni-kshay |
14/06/2023 |
|
| 269 |
Recording missed doses in Ni-kshay |
14/06/2023 |
|
| 830 |
Ni-kshay Poshan Yojana |
14/06/2023 |
|
| 5044 |
Epidemiology of LNTB |
17/06/2023 |
|
| 585 |
Epidemiological Triad of TB |
17/06/2023 |
|
| 10 |
Epidemiology and burden of TB |
17/06/2023 |
|
| 5045 |
Pathogenesis of LNTB |
17/06/2023 |
|
| 5048 |
Investigations for LNTB |
17/06/2023 |
|
| 5049 |
Microbiological confirmation in LNTB |
17/06/2023 |
|
| 5050 |
Management of LNTB |
17/06/2023 |
|
| 5043 |
Lymph node Tuberculosis [LNTB] |
17/06/2023 |
|
| 5053 |
Response to Treatment in LNTB |
17/06/2023 |
|
| 5051 |
Follow up in Treatment of LNTB |
17/06/2023 |
|
| 5052 |
LNTB Clinical Scenarios |
17/06/2023 |
|
| 5089 |
Presumptive Cutaneous TB |
20/06/2023 |
|
| 5090 |
Lupus vulgaris |
20/06/2023 |
|
| 5091 |
Scrofuloderma |
20/06/2023 |
|
| 5092 |
Tuberculosis verrucosa cutis |
20/06/2023 |
|
| 5094 |
Management and follow-up of cutaneous TB |
20/06/2023 |
|
